For metastatic prostate cancer, when would you add carboplatin to docetaxel or cabazitaxel?

Topics: Genitourinary Cancers • Prostate Cancer • Medical Oncology • NCI-CCC Tumor Board Question • Johns Hopkins • NCI-CCC GU Tumor Board Question

Answer from: Medical Oncologist at Academic Institution

There is no clear consensus on this topic. However, I consider carboplatin plus docetaxel or cabazitaxel in men with the following features who are fit for chemotherapy and wish to be aggressive in their care, based on Paul Corn's MD Anderson trial (PMID 31515154): Aggressive variant phenotypic fea...

Comments

Medical Oncologist at Conway Regional Health System
Where is the role for Cis/etoposide based regimen,...

Related Questions